While continuous positive airway pressure (CPAP) therapy has a strong evidence base for
the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity …

Background: Obstructive sleep apnoea (OSA) is highly prevalent and significantly
associated with major adverse cardiovascular events (MACEs). Continuous positive airway …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …

Aims To assess whether continuous positive airway pressure (CPAP) therapy reduces major
adverse cardiovascular events (MACE) in patients with moderate-to-severe obstructive …

Methods This trial was a multicentre, randomised, parallel-group, open-label trial with
blinded end point assessment. Participants with a history of coronary artery disease or …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

Extract Obstructive sleep apnoea (OSA) is the most common form of sleep disordered
breathing, affecting nearly one billion middle-aged individuals worldwide [1]. OSA is …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Increased cardiovascular (CV) morbidity and death are linked to obstructive sleep apnoea
(OSA). The primary method of treating OSA is continuous positive airway pressure (CPAP) …

RATIONALE: Obstructive sleep apnea (OSA) is associated with an increased risk of
cardiovascular adverse events (CVE) that would be reduced with its treatment with …